Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 492.80
Change Today 0.00 / 0.00%
Volume 0.0
EMIT On Other Exchanges
Tel Aviv
As of 7:24 AM 10/1/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

BSR tower 3

5 Kineret Street

Bnei Brak, 5112301


Phone: 972 3 608 6000

Fax: 972 3 608 6050

Elbit Imaging Ltd., together with its subsidiaries, engages in commercial and entertainment centers, hotels, medical, and residential projects businesses in Israel, Western Europe, Central and Eastern Europe, and internationally. Segments The company’s segments include Commercial Centers, Hotels, Medical Industries, and Residential Projects. Commercial Centers segment Commercial and Entertainment Centers: This business includes initiation, construction, and sale of commercial and entertainment centers and other mixed-use real property projects, predominantly in the retail sector, located in Central and Eastern Europe and in India, primarily through its subsidiary, Plaza Centers N.V (PC). The company’s commercial centers are comprised of large retail anchor tenants. These anchor tenants form the basis of the shopping areas around which smaller boutiques, international brands and local retailers create a balanced tenant mix to meet local demand. Leases with anchor tenants run for a term of 10 to 15 years, with an option to extend. Leases with semi-anchor tenants are usually for a term of 5 to 10 years, while standard units are usually leased for 3 to 5 years. The company’s commercial centers also include a multiplex cinema complex of between 4 and 12 theater screens, depending on the size of the center, and, where appropriate, an IMAX auditorium. Each entertainment area also includes a food court offering a range of food outlets, coffee shops and restaurants. Operational commercial centers: PC operates and manages six active commercial and entertainment centers. Hotels segment This business includes hotel operations and management. It focuses on developing or acquiring, holding and operating, generally via management companies, deluxe hotel properties, that are located near major transportation stations which provide the business and vacation traveler with upscale accommodation. The company’s hotels in Belgium are wholly owned while its holding in the Radisson Blu in Bucharest is 77% and the rest is owned by various unrelated third parties. Rezidor Hotel Group (Rezidor) manages two of its hotels in Belgium and Radisson Blu hotel complex in Romania. Customer base: The hotels’ principal target customer base is the business traveler and the tourist industry, both individuals and in groups. Strategy: The company’s strategy for the hotel business is to increase the performance of hotels' portfolio. The duration of holding and managing of hotel portfolio varies and is dependent upon business cycles, economic conditions, property yields, and trends affecting the hotel industry or capital market opportunities. Medical Industries segment This business includes research and development, and production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment; and development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine. The company holds 88.4% of Elbit Medical Technologies Ltd.'s (Elbit Medical) share capital. The company indirectly holds, through Elbit Medical, approximately 36% of the outstanding share capital of InSightec Ltd. (InSightec). InSightec is engaged in the research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment. InSightec develops and markets the ExAblate, the FDA-approved system for magnetic resonance imaging guided focused ultrasound treatment equipment (MRgFUS). InSightec’s objective is to transform the surgical environment for the treatment of a limited number of forms of benign and malignant tumors by replacing invasive and minimally invasive surgical procedures with an incision-less surgical treatment solution. The system is designed to deliver non-invasive treatments while reducing the risk of disease, potential complications, as well as the direct and indirect costs associated with surgery. InSightec has an installed base of approximately 100 units in academic hospitals, community hospitals, MRI clinics and physician-formed joint ventures. InSightec’s MRgFUS technology integrates the ther


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EMIT:IT 492.80 0.00

EMIT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arihant Foundations & Housing Ltd 34.00 INR +0.10
Globe Trade Centre SA 6.44 PLN +0.21
Olympia Industries Bhd 0.11 MYR +0.005
Prestige Estates Projects Ltd 211.75 INR -2.30
Phoenix Mills Ltd/The 323.05 INR +4.80
View Industry Companies

Industry Analysis


Industry Average

Valuation EMIT Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELBIT IMAGING LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at